Arkolith/Insider Trading/FHTX/Form 4

Maynard Ryan D

Chief Financial OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Feb 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 23, 2026Grant(A)400K$5.75$2.3M400K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001363984-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML